移植診断の世界市場レポート 2024

移植診断の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.3%の年間複合成長率（CAGR）で25億7,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、患者中心のアプローチ、規制の適応、生体ドナー移植の増加、個別化された移植医療、および移植手術の全体的な成長によるものと考えられます。予測期間に予想される主な動向には、教育および啓発プログラム、市場拡大戦略、規制ガイドラインの進化、免疫抑制療法の最適化、バイオマーカーの開発などが含まれます。

急性疾患の発生率の増加は臓器不全率の上昇に寄与し、移植処置の需要の高まりにつながり、その後移植診断市場を推進しています。臓器移植は複雑なプロセスであり、その成功はドナーの臓器とレシピエントの身体システムの適合性にかかっています。臓器移植の成功の可能性を評価するために、診断検査が実施されます。米国の臓器移植を監督する非営利団体、ユナイテッド・ネットワーク・フォー・オルガン・シェアリングによると、2021年には臓器移植数が記録的な数字を記録しました。特に、2021年には腎臓移植が24,669件、肝臓移植が9,236件、心臓移植が3,817件行われました。この診断検査の需要の急増は、移植診断市場の重要な推進力となっています。

臓器移植の普及の増加は、移植診断市場の成長を促進すると予想されます。臓器移植は、ドナーからレシピエントに移植される臓器、組織、または細胞の除去を伴い、転帰と適合性評価の改善において重要な役割を果たします。 移植診断は、移植前のドナー適格性スクリーニング、移植後の合併症の特定、抗菌薬の有効性のモニタリングに不可欠です。例えば、ユナイテッド臓器共有ネットワークは、2022年1月の時点で、2021年の米国における臓器移植件数は4万1,354件に達し、前年比5.9％増加し、初めて4万件の大台を突破したと報告しました。したがって、臓器移植の数の増加が、移植診断市場の主要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の移植診断市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 試薬と消耗品
• 機器
• ソフトウェアとサービス
• 世界の移植診断市場、移植タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 固体臓器
• 幹細胞
• 世界の移植診断市場、臓器別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 腎臓
• 肝臓
• 心臓
• 肺
• 膵臓
• 世界の移植診断市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 非分子アッセイ
• 分子アッセイ
• 世界の移植診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院と移植センター
• 研究および移植センター
• 商用サービスプロバイダー

第7章 地域および国の分析

• 世界の移植診断市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の移植診断市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 移植診断市場の競合情勢
• 移植診断市場の企業プロファイル
  • F. Hoffmann La-Roche AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories Inc.
  • Becton-Dickinson and Company
  • Hologic Inc.

第31章 その他の大手および革新的な企業

• Illumina Inc.
• BioMerieus SA
• Biomerieux SA
• Grafton Companies
• Bio-rad Laboratories Inc.
• Sigma-Aldrich Corporation
• Qiagen NV
• Immucor Transplant Diagnostics Inc.
• Immucor Inc.
• Luminex Corporation
• Affymetrix Inc.
• CareDx Company
• One Lambda Inc.
• Eurobio Scientific Group
• Gendx BV

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Transplant diagnostics encompass tests performed prior to the transplantation of a donor organ to the recipient patient. In the context of organ transplantation and hematopoietic stem cell transplantation, transplantation diagnostics primarily focus on histocompatibility and immunogenetics.

The primary categories within the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostics instruments are specifically designed products aimed at enhancing the speed and quality of transplant diagnostics. Employing non-molecular assay and molecular assay technologies, transplant diagnostics cover various organs such as kidneys, liver, heart, lungs, and pancreas. The transplant types involved are solid organ and stem cells, with end-users including hospitals and transplant centers, research laboratories and transplant centers, as well as commercial service providers.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transplant diagnostics market size has grown rapidly in recent years. It will grow from $1.82 billion in 2023 to $2.01 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed in the historical period can be ascribed to the advancement of HLA typing, the expansion of organ transplantations, progress in immunosuppressive therapy, the introduction of cross-matching techniques, and the standardization of regulatory measures.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth in the forecast period can be credited to patient-centric approaches, regulatory adaptations, an increase in living donor transplants, personalized transplant medicine, and the overall growth in transplant procedures. Major trends expected in the forecast period include education and awareness programs, strategies for market expansion, the evolution of regulatory guidelines, optimization of immunosuppressive therapy, and the development of biomarkers.

The increasing incidence of acute diseases is contributing to a rise in organ failure rates, leading to a heightened demand for transplant procedures and subsequently propelling the transplant diagnostics market. Organ transplantations are intricate processes, and the success of such procedures hinges on the compatibility of the donor's organ with the recipient's body system. To assess the potential success of organ transplants, diagnostic tests are conducted. According to the United Network for Organ Sharing, a non-profit organization overseeing organ transplantation in the US, the year 2021 witnessed a record-setting number of organ transplants. Notably, 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplant procedures were conducted in 2021. This surge in demand for diagnostic tests is a significant driver for the transplant diagnostics market.

The increasing prevalence of organ transplants is anticipated to fuel the transplant diagnostics market's growth. Organ transplantation, involving the removal of organs, tissues, or cells from a donor to be transplanted into a recipient, plays a critical role in improving outcomes and compatibility assessment. Transplant diagnostics are essential for pre-transplant donor eligibility screening, identification of post-transplant complications, and monitoring the effectiveness of antimicrobial agents. For example, as of January 2022, the United Network for Organ Sharing reported that the number of organ transplants in the United States reached 41,354 in 2021, marking a 5.9% increase from the previous year and surpassing the 40,000 milestone for the first time. Consequently, the growing number of organ transplants is a key driver for the transplant diagnostics market.

The substantial gap between organ donation and the demand for organ transplantation poses a challenge to the transplant diagnostics market's growth. The insufficient number of organ donors falls significantly short of meeting the increasing demand for organ transplants. As of 2021, the Health Resources and Services Administration reported that 106,090 people were on the waiting list for organ donations. This widening gap between organ supply and demand contributes to a deficit of organ donors, limiting the requirement for transplant diagnostic tests and devices and consequently impeding market growth.

Prominent companies in the transplant diagnostics market are strategically introducing advanced services to enhance their market profitability. Advanced transplant diagnostic services entail the utilization of innovative diagnostic tools and technologies to enhance the precision and efficiency of pre-transplant and post-transplant testing procedures. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, unveiled Quest Advanced Specialized Transplant Services, an extensive array of cutting-edge diagnostics and support services designed to enhance access to laboratory tests for solid organ, human cell, and tissue transplants. This comprehensive offering includes over 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results integrated into the physician's electronic medical record (EMR), and 24/7 support services, including medical consultation to ensure appropriate test selection and result interpretation impacting patient care. The new services expand upon Quest's previous transplant testing offerings with added capabilities, including patient-customized information packets and expedited testing for patients visiting Quest's 2,100 patient service centers, with some test results obtainable within 8-24 hours.

Companies are increasingly adopting Next Generation Sequencing (NGS) for donor-recipient matching tests. NGS technology facilitates the sequencing of an entire human genome, enabling the matching of genes between donors and recipients to determine the suitability for organ transplantation. Virtually all current transplant diagnostic tests and devices leverage NGS technology to inform decisions related to organ transplantation. Castle Biosciences, for instance, introduced the Decision Dx-CMSeq Test, utilizing NGS (Next Generation Sequencing) to identify somatic mutations in genes.

In August 2022, Eurobio Scientific, a biotechnology company based in France, completed the acquisition of GenDx for $134.3 million (€135 million). This strategic move is anticipated to bolster Eurobio's research efforts in the field of transplantation. GenDx is a molecular diagnostics startup headquartered in the Netherlands.

Major companies operating in the transplant diagnostics market report are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive PLC, BioGenuix, Pure Transplant Solutions

North America was the largest region in the transplant diagnostics market in 2023. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Reagent & Consumables; Instrument; Software & Services
• 2) By Transplant Type: Solid Organ; Stem Cell
• 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
• 4) By Technology: Non Molecular Assay; Molecular Assay
• 5) By End User: Hospitals and Transplant Centers; Research Laboratories & Transplant Centers; Commercial Service Providers
• Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transplant Diagnostics Market Characteristics

3. Transplant Diagnostics Market Trends And Strategies

4. Transplant Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Transplant Diagnostics Market Size and Growth

• 5.1. Global Transplant Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Transplant Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Transplant Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Transplant Diagnostics Market Segmentation

• 6.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Reagent & Consumables
• Instrument
• Software & Services
• 6.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Solid Organ
• Stem Cell
• 6.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Kidney
• Liver
• Heart
• Lung
• Pancreas
• 6.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Non Molecular Assay
• Molecular Assay
• 6.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals and Transplant Centers
• Research Laboratories & Transplant Centers
• Commercial Service Providers

7. Transplant Diagnostics Market Regional And Country Analysis

• 7.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Transplant Diagnostics Market

• 8.1. Asia-Pacific Transplant Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Transplant Diagnostics Market

• 9.1. China Transplant Diagnostics Market Overview
• 9.2. China Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Transplant Diagnostics Market

• 10.1. India Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Transplant Diagnostics Market

• 11.1. Japan Transplant Diagnostics Market Overview
• 11.2. Japan Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Transplant Diagnostics Market

• 12.1. Australia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Transplant Diagnostics Market

• 13.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Transplant Diagnostics Market

• 14.1. South Korea Transplant Diagnostics Market Overview
• 14.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Transplant Diagnostics Market

• 15.1. Western Europe Transplant Diagnostics Market Overview
• 15.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Transplant Diagnostics Market

• 16.1. UK Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Transplant Diagnostics Market

• 17.1. Germany Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Transplant Diagnostics Market

• 18.1. France Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Transplant Diagnostics Market

• 19.1. Italy Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Transplant Diagnostics Market

• 20.1. Spain Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Transplant Diagnostics Market

• 21.1. Eastern Europe Transplant Diagnostics Market Overview
• 21.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Transplant Diagnostics Market

• 22.1. Russia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Transplant Diagnostics Market

• 23.1. North America Transplant Diagnostics Market Overview
• 23.2. North America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Transplant Diagnostics Market

• 24.1. USA Transplant Diagnostics Market Overview
• 24.2. USA Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Transplant Diagnostics Market

• 25.1. Canada Transplant Diagnostics Market Overview
• 25.2. Canada Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Transplant Diagnostics Market

• 26.1. South America Transplant Diagnostics Market Overview
• 26.2. South America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Transplant Diagnostics Market

• 27.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Transplant Diagnostics Market

• 28.1. Middle East Transplant Diagnostics Market Overview
• 28.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Transplant Diagnostics Market

• 29.1. Africa Transplant Diagnostics Market Overview
• 29.2. Africa Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Transplant Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Transplant Diagnostics Market Competitive Landscape
• 30.2. Transplant Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann La-Roche AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Becton-Dickinson and Company
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Hologic Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Transplant Diagnostics Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. BioMerieus S.A
• 31.3. Biomerieux SA
• 31.4. Grafton Companies
• 31.5. Bio-rad Laboratories Inc.
• 31.6. Sigma-Aldrich Corporation
• 31.7. Qiagen N.V.
• 31.8. Immucor Transplant Diagnostics Inc.
• 31.9. Immucor Inc.
• 31.10. Luminex Corporation
• 31.11. Affymetrix Inc.
• 31.12. CareDx Company
• 31.13. One Lambda Inc.
• 31.14. Eurobio Scientific Group
• 31.15. Gendx BV

32. Global Transplant Diagnostics Market Competitive Benchmarking

33. Global Transplant Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Transplant Diagnostics Market

35. Transplant Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Transplant Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Transplant Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Transplant Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer